Related Experiment Videos
[Novel affinity membrane used for bilirubin removal]
1Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116012, China.
Se Pu = Chinese Journal of Chromatography
|January 25, 2003
Summary
Two new cellulose-based affinity membranes effectively remove toxic bilirubin from blood. Immobilized with poly-D-lysine or quaternary ammonium salt, these membranes show high efficiency in buffer and HSA solutions.
Area of Science:
- Biomaterials Science
- Chemical Engineering
- Biomedical Engineering
Context:
- Bilirubin is a toxic byproduct of heme metabolism, elevated levels of which indicate hepatic dysfunction.
- Current methods for bilirubin removal may have limitations in efficiency and specificity.
- Developing effective artificial membranes for blood detoxification is crucial for managing liver diseases.
Purpose:
- To synthesize and characterize two novel cellulose-based affinity membranes for bilirubin removal.
- To immobilize poly-D-lysine and quaternary ammonium salt ligands onto cellulose supports for enhanced bilirubin binding.
- To evaluate the performance of these membranes in removing bilirubin from aqueous solutions under various experimental conditions.
Summary:
- Two novel affinity membranes were prepared by chemically grafting cellulose with poly-D-lysine or quaternary ammonium salt ligands.
- The membranes demonstrated significant bilirubin removal efficiency, exceeding 70% from phosphate buffer and at least 50% from low concentration human serum albumin (HSA) solutions.
- Optimized conditions include higher temperatures, a 4-hour adsorption time in static experiments, and adjustable flow rates in dynamic experiments.
Impact:
- These novel affinity membranes offer a promising approach for extracorporeal detoxification in patients with hepatic disorders.
- The study provides valuable insights into the design and optimization of affinity membranes for targeted toxin removal.
- Successful bilirubin clearance using these membranes could lead to improved patient outcomes and reduced healthcare burdens associated with liver disease.